2015•Science AdvancesOpen access

Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation

Jun Tang, Mark E. Lobatto, Laurien Hassing, Susanne E. M. van der Staay, Sarian M. van Rijs, Claudia Calcagno, Mounia Sabrina Braza, Samantha Baxter, François Fay, Brenda L. Sánchez-Gaytán, Raphaël Duivenvoorden, Hendrik B. Sager, Yaritzy M. Astudillo, Wei Leong, Sarayu Ramachandran, Gert Storm, Carlos Pérez‐Medina, Thomas Reiner, David P. Cormode, Gustav J. Strijkers, Erik S.G. Stroes, Filip K. Świrski, Matthias Nahrendorf, Edward A A Fisher, Zahi Adel Fayad, Willem J. M. Mulder

Open full text 233 citations

Abstract

) with advanced atherosclerotic plaques. This resulted in rapid reduction of plaque inflammation and favorable phenotype remodeling. We then combined this short-term nanoparticle intervention with an eight-week oral statin treatment, and this regimen rapidly reduced and continuously suppressed plaque inflammation. Our results demonstrate that pharmacologically inhibiting local macrophage proliferation can effectively treat inflammation in atherosclerosis.

Open-access reader

About this research paper

What this paper is about

) with advanced atherosclerotic plaques. This resulted in rapid reduction of plaque inflammation and favorable phenotype remodeling. We then combined this short-term nanoparticle intervention with an eight-week oral statin treatment, and this regimen rapidly reduced and continuously suppressed plaque inflammation. Our results demonstrate that pharmacologically inhibiting local macrophage proliferation can effectively treat inflammation in atherosclerosis.

Why it matters

OpenAlex reports 233 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

) with advanced atherosclerotic plaques. This resulted in rapid reduction of plaque inflammation and favorable phenotype remodeling. We then combined this short-term nanoparticle intervention with an eight-week oral statin treatment, and this regimen rapidly reduced and continuously suppressed plaque inflammation. Our results demonstrate that pharmacologically inhibiting local macrophage proliferation can effectively treat inflammation in atherosclerosis.

Key concepts: Inflammation, Macrophage, Vulnerable plaque, Immunology, Medicine, Pathology, Biology, In vitro

Related papers

Back to paper searchBrowse research topicsOriginal source
Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation — Research Paper | ScholarLens